What BPH Energy does

BPH Energy Limited (ASX: BPH) is a Perth-based, publicly listed diversified investment holding company that acquires and develops minority and majority stakes in unlisted resource and biomedical technology companies. Its core holdings include a 36% interest in Advent Energy, an unlisted oil and gas exploration company operating the PEP 11 permit in the offshore Sydney Basin (up to 13.2 Tcf prospective recoverable gas) and Retention Lease 1 in the Onshore Bonaparte Basin, alongside a 10% stake in US-based Clean Hydrogen Technologies, which is developing catalysts and processes to produce clean hydrogen and conductive carbon black from natural gas with no CO2 emissions. The company also holds and commercialises biomedical technologies through investee companies Cortical Dynamics (the EEG-based Brain Anaesthesia Response Monitor, or BARM, with extensive granted patents across major jurisdictions) and Molecular Discovery Systems (the HLS5 tumor suppressor gene platform targeting cancer, Huntington's, Parkinson's and HIV).

BPH operates with 1-10 employees and generates no direct product revenue, functioning instead as an investor-operator. Its business model relies on capital raises (Entitlement Issue August 2022, Options Placement December 2025), equity stakes in portfolio companies, and the future potential for licensing royalties (hydrogen, HLS5), hardware sales (BARM), or production revenue (Advent Energy). Customers and target segments are defined at the portfolio company level — gas utilities and energy companies in eastern Australia for Advent Energy, hospitals and surgical centres for Cortical Dynamics, and pharmaceutical partners for Molecular Discovery Systems. The company is also pursuing environmental services opportunities through a subsidiary (BPH Global) engaged with Indonesia's National Economic Council on bioremediation of mining-affected waterways. BPH Energy's go-to-market is investor-relations led via ASX announcements, its corporate website, and investor webinars.

Name

BPH Energy

Legal name

BPH Energy Limited

Website

https://www.bphenergy.com.au/

Company type

Public

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

BPH Energy Limited (ASX: BPH) is a Perth-based, publicly listed investment holding company that holds equity stakes in unlisted oil and gas exploration (Advent Energy), clean hydrogen production (Clean Hydrogen Technologies), and biomedical technology companies (Cortical Dynamics, Molecular Discovery Systems).

Ownership category

akta.pro rank

Product category

Diversified Energy and Biotech Investments

NAICS

Fossil Fuel Electric Power Generation (221112), Hydroelectric Power Generation (221111)

SIC

Crude Petroleum & Natural Gas (1311)

akta.pro primary industry

Chemical/Fuel-Based LDES (Hydrogen-to-Power, Ammonia, LOHC, Synthetic Fuels) (EUAFADAE)

akta.pro secondary industries

Hydrogen CHP (Fuel Cell & H2-Ready Turbines) (EUACAKAF), Fuel Cell CHP (SOFC/PEM—Natural Gas/Biogas/Hydrogen) (EUACAKAG), Spent Fuel Pool (SFP) Operations & Upgrades (EUAKAHAA)

Keywords

• Investment holding company
• Oil gas exploration
• Medical device monitoring
• Clean hydrogen technology
• Biotechnology drug discovery

Headquarters

HQ city

Perth

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Oil and Gas Exploration: Through 36% owned Advent Energy, BPH participates in oil and gas exploration and production, including the significant PEP 11 permit in the Offshore Sydney Basin with multi-Tcf gas prospective resources.
2. Clean Hydrogen Technology Investment: Investment in Clean Hydrogen Technologies (10% stake) which is developing commercial hydrogen production systems generating clean hydrogen and conductive carbon for battery manufacturing.
3. Medical Device Commercialization: Cortical Dynamics is commercializing the BARM brain monitoring system for surgical anesthesia optimization, with completed first human clinical trials.
4. Biotechnology/Drug Discovery: Molecular Discovery Systems focuses on HLS5 tumor suppressor gene for cancer therapeutics and other disease applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

BPH Energy is a publicly listed diversified holding company that acquires and commercializes stakes in oil and gas exploration (36% in Advent Energy, including the PEP 11 permit), clean hydrogen production technology (10% in Clean Hydrogen Technologies), medical devices (BARM brain monitor via Cortical Dynamics), and biotechnology for drug discovery (HLS5 gene via Molecular Discovery Systems).

Product overview

BPH Energy is a diversified investment company holding a 36% interest in unlisted oil and gas explorer Advent Energy Ltd, alongside a portfolio of Australian biomedical technologies. The company operates through four main investment vehicles: Advent Energy Limited (oil and gas exploration with PEP 11 offshore permit and Retention Lease 1), Cortical Dynamics with its Brain Anaesthesia Response Monitor (BARM) EEG-based medical device, Molecular Discovery Systems focused on HLS5 Tumor Suppressor Gene for drug discovery, and Clean Hydrogen Technologies for clean hydrogen production.

Differentiator

Problem solved

Functional benefit

Brands

• Brain Anaesthesia Response Monitor (BARM): Cortical Dynamics' device that measures patient brain electrical activity (EEG) to indicate response to drugs administered during surgery.

Products and services

• Advent Energy Limited Unlisted oil and gas exploration and production company holding Petroleum Exploration Permit 11 (PEP 11) in the offshore Sydney Basin and Retention Lease 1 in the Onshore Bonaparte Basin (Weaber Gas Field); $81M historic exploration expenditure on portfolio.
• PEP 11 Oil and Gas Permit Offshore Sydney Basin exploration permit targeting multi-Tcf prospective gas resources, near the Sydney-Wollongong-Newcastle demand centre.
• Retention Lease 1 (Weaber Gas Field) Onshore Bonaparte Basin retention licence covering the Weaber Gas Field, with near-term conventional gas development potential for local Australian markets.
• Brain Anaesthesia Response Monitor (BARM) EEG-based medical device developed by Cortical Dynamics that measures brain electrical activity to detect the effect of anaesthetic agents, helping anaesthetists keep patients optimally anaesthetised during surgery; patented across Australia, NZ, US, Japan, China, UK, Germany, France, Sweden and other European countries.
• HLS5 Tumor Suppressor Gene Program Tumor suppressor gene platform developed by Molecular Discovery Systems for drug discovery and biomarker validation, with applications in cancer, Huntington's, Parkinson's, and HIV; underpinned by an extensive granted patent portfolio.
• Clean Hydrogen Production Technology Hydrogen production technology that generates clean hydrogen and conductive carbon (for battery manufacturing) by processing natural gas with proprietary catalysts and bespoke engineering processes, with no CO2 emissions.

Quantifiable outcome

• 79% of wells drilled in positive geochemical anomalies resulted in commercial oil and gas discoveries
• +1 more outcomes

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Asset Energy Pty LimitedcoreOthers · 23 February 2026Asset Energy Pty Limited is a wholly-owned subsidiary of BPH Energy that operates the PEP 11 permit. BPH and Bounty Oil & Gas appeared before Federal Court of Australia in February 2026 for judicial review hearing challenging Joint Authority's refusal of PEP 11 permit extension applications.
• Indonesia National Economic CouncilminorStrategic or Co-development Partner · 15 July 2025BPH Global (subsidiary) has begun discussions with Indonesia's National Economic Council about deploying bioremediation services to rehabilitate coastlines and waterways affected by mining operations, targeting nickel and coal industries.
• Bounty Oil & Gas NLcoreStrategic or Co-development PartnerJoint Venture partner holding 15% of Petroleum Exploration Permit PEP 11. Bounty Oil & Gas NL (ASX: BUY) is the joint venture partner with Advent Energy's wholly owned subsidiary Asset Energy Pty Ltd holding 85% interest.

Scale indicators8 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Bounty Oil & Gas NL: ASX-listed (BUY) small-cap Australian oil and gas explorer that is BPH's JV partner on PEP 11 (15% interest). Directly comparable in scale, geography and asset mix.
• Strike Energy Limited: ASX-listed (STX) Australian gas-focused exploration and development company pursuing unconventional and conventional gas resources. Comparable Australian gas-focused small-cap with similar upstream profile.
• Empire Energy Group Limited: ASX-listed (EEG) gas exploration company with onshore (Northern Territory Beetaloo) and offshore conventional gas assets. Closely comparable Australian small-cap E&P with similar regulatory and capital-intensity profile.
• Central Petroleum Limited: ASX-listed (CTP) Australian onshore oil and gas exploration and production company with conventional gas assets in the NT and Queensland. Comparable size and Australian gas-focused business model.
• Hazer Group Limited: ASX-listed (HZR) emerging hydrogen production technology company using natural gas as feedstock, analogous to BPH's Clean Hydrogen Technologies stake. Similar pre-commercial hydrogen stage and Australian listing.
• MEC Resources Limited: ASX-listed (MMR) diversified investment holding company chaired by David Breeze, holding minority stakes in oil & gas and resources ventures. Closest structural analogue to BPH as a small-cap ASX investment vehicle.

Emerging players

• CPH2 Clean Energy: London-listed (CPH2) emerging clean hydrogen equipment company developing novel hydrogen generators. Comparable as a small-cap pre-commercial hydrogen technology peer.

Broad incumbents

• Masimo Corporation: NASDAQ-listed (MASI) large-scale patient monitoring company with EEG-based brain monitoring products (e.g., SedLine). Relevant broader incumbent in the same addressable market as Cortical Dynamics' BARM.
• ITM Power plc: London-listed (ITM) established hydrogen production and refueling equipment supplier. Comparable broad incumbent in the hydrogen technology category that BPH's CHT investment addresses.
• Santos Limited: ASX-listed (STO) major Australian oil and gas producer with significant domestic gas operations relevant to eastern Australia supply. Broad incumbent comparable for the gas end-market BPH's PEP 11 targets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/BPHEnergyLTD
• LinkedInlinkedin.com/company/bph-energy

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BPH Energy